|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.7 CHF | -0.12% |
|
+1.46% | -2.46% |
| Apr. 27 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
| Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
BB Biotech AG announced that shareholder elected Dr. Pearl Huang and Laura Hamill as new members of its board. Dr. Pearl Huang has spent over 30 years in the pharma and biotech industries. She is currently a member of the Board of directors of Walters Corporation, KSQ Theraputics Inc., MIT Corporation.
Ms. Laura Hamill brings more than 30 years of experience in the biopharma industry. She is currently a member of the Board of directors of Anaptysbio Inc., Y-mAbs Theraputics Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.46% | 2.52B | |
| +41.79% | 50.93B | |
| -0.56% | 42.12B | |
| +49.62% | 42.05B | |
| -7.20% | 29.18B | |
| +12.59% | 26.02B | |
| -21.51% | 18.9B | |
| +6.92% | 13.21B | |
| +24.91% | 12.17B | |
| +29.60% | 12.16B |
BB BIOTECH AG 